Pattern of Utilization of Blood and Blood Products in a Tertiary Care Hospital
Keywords:
Blood Components, Internal Quality Control, Transfusion Practices, Transfusion Audits, Utilisation PatternAbstract
Background: Blood banks should be aimed at high quality of transfusion practices in terms of standard practices from screening of donors, collection, separation and issue of blood and blood products. Regular transfusion audits should be carried out in the blood bank to know the utilization trends.
Aims and Objectives: To study the utilization pattern of blood and blood components in a tertiary care hospital.
Materials and Methods: It was a retrospective cross-sectional study carried out at the blood bank of a tertiary care hospital for a period of three years from 2015-2017. Details of collection of whole blood, preparation of components, departments requesting blood products were collected from the records of the blood bank. Data entered in excel and frequency and distribution of variables were calculated.
Result: A total of 10072 blood components were prepared during the study period of three years. Out of the 2372 whole blood collected during the study period, 1981 (83.5%) were utilized. Out of the 4961 components prepared, 4726 (95.3%) of packed cells, 2942 (59.3%) of platelets, 4516 (91%) of Fresh frozen plasma was utilized. During the study period, Obstetrics and Gynecology department requested 3610 (35.8%) blood products, followed by Orthopedics department 2098 (20.8%).
Conclusion: Every blood bank should audit the pattern of utilization of blood and blood products which can serve as an internal quality control for the effective functioning of blood bank. A good communication between the clinicians and the blood bank personnel will minimize the inappropriate usage of blood and blood products.
References
Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications.
Am Fam Physician 2011; 83(6): 719-724.
Alving B, Alcorn K. How to improve transfusion medicine a treating physician’s perspective. Arch Pathol Lab Med 1999; 123: 492-495.
Gahine R, Das A, Pratima Kujur P et al. An audit of the pattern of blood transfusion at a tertiary care centre.
Indian J Pathol Oncol 2015; 2(3): 118-120.
Hawkins TE, Carter JM, Hunter PM. Can mandatory pretransfusion approval programmes be improved?
Transfus Med Oxf Engl 1994; 4(1): 45-50.
Joshi GP, Landers DF. Audit in transfusion practice. J Eval Clin Pract 1998; 4(2): 141-146.
Cheng G, Wong HF, Chan A et al. The effects of a self-educating blood component request form and
enforcements of transfusion guidelines on FFP and platelet usage. Queen Mary Hospital, Hong Kong. British
Committee for Standards in Hematology (BCSH). Clin Lab Haematol 1996; 18(2): 83-87.
Friedman BA, Oberman HA, Chadwick AR et al. The maximum surgical blood order schedule and surgical
blood use in the United States. Transfusion (Paris) 1976; 16(4): 380-287.
Olawumi HO, Bolaji BO. Blood utilization in elective surgical procedures in Ilorin. Trop J Health Sci 2006;
(1): 15-17.
Mead JH, Anthony CD, Sattler M. Hemotherapy in Elective Surgery. An incidence report, review of the
literature, and alternatives for guideline appraisal. Am J Clin Pathol 1980; 74(2): 223-227.
Zubair Qureshi M, Sawhney V et al. Utilisation of blood components in a tertiary care hospital. Int J Curr Res
Rev 2015; 07: 1-7.
Tinmouth A, Macdougall L, Fergusson D et al. Reducing the amount of blood transfused: a systematic review
of behavioral interventions to change physicians’ transfusion practices. Arch Intern Med 2005; 165(8):
-852.
Greeno E, McCullough J, Weisdorf D. Platelet utilization and the transfusion trigger: a prospective analysis.
Transfusion (Paris) 2007; 47(2): 201-205.
Makroo RN, Raina V, Kumar P et al. A prospective audit of transfusion requests in a tertiary care hospital for
the use of fresh frozen plasma. Asian J Transfus Sci 2007; 1(2): 59.
Agarwal N, Subramanian A, Pandey RM et al. An audit of fresh frozen plasma usage in a tertiary trauma care
centre in North India. Indian J Hematol Blood Transfus. 2014; 30(4): 328-332.
Chaudhary R, Singh H, Verma A et al. Evaluation of fresh frozen plasma usage at a tertiary care hospital in
North India. ANZ J Surg. 2005; 75(7): 573-576.
Blumberg N, Laczin J, McMican A et al. A critical survey of fresh-frozen plasma use. Transfusion (Paris) 1986;
(6): 511-513.
Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate
transfusion in New South Wales public hospitals. Med J Aust 2003; 178(3): 117-121.
Beloeil H, Brosseau M, Benhamou D. Transfusion of fresh frozen plasma (FFP): audit of prescriptions. Ann
Fr Anesth Reanim 2001; 20(8): 686-692.
Schiffer CA. Prophylactic platelet transfusion. Transfusion (Paris) 1992; 32(4): 295-298.
Slichter SJ. Controversies in platelet transfusion therapy. Annu Rev Med 1980; 31: 509-540.
Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusions for patients with haematological
malignancies: who needs them? Br J Haematol 2011; 154(4): 425-440.
Wallace EL, Churchill WH, Surgenor DM et al. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion (Paris) 1998; 38(7): 625-636.
Freireich EJ. Supportive care for patients with blood disorders. Br J Haematol 2000; 111(1): 68-77.
Downloads
Published
Issue
Section
License
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
